Home/Vaccizone/Alper Türken

AT

Alper Türken

Non-Executive Director of Management Board

Therapeutic Areas

Infectious Disease Oncology Veterinary Health

Vaccizone Pipeline

Drug	Indication	Phase
COVID-19 Vaccine	COVID-19/SARS-CoV-2	Pre-clinical
Melanoma Immunotherapy	Melanoma	Pre-clinical
Veterinary Vaccines	Undisclosed Animal Diseases	Pre-clinical

Leadership Team at Vaccizone

Prof. Dr. Nesrin Özören

CEO & Chief Scientific Officer

Chief Operating Officer

Chief Financial Officer

Prof. Dr. H.J. Schmitt

Head of Medical Affairs

View full Vaccizone profile